BioSpace News Archive

Beleave Inc. is pleased to announce its intention to complete a non-brokered private placement (the “Non-Brokered Offering”) of up to 2,500,000 units of the Company at a price of $2.00 per unit for gross proceeds of approximately $5 million.

Market research firm Technavio has announced the release of their latest report on the neurodiagnostic and monitoring devices market in the US.

Market research firm Technavio has announced the release of their latest report on the global moist wound dressings market.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against MabVax Therapeutics Holdings, Inc.

Amgen will present at the Goldman Sachs 39th Annual Global Healthcare Conference at 1:20 p.m. PT on Tuesday, June 12, 2018, in Rancho Palos Verdes, Calif.

Khiron life Sciences Corp. will open the market of the TSX Venture Exchange on Monday, June 11, 2018 at 9:30 a.m. EDT.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Rockwell Medical, Inc. (NasdaqGM: RMTI).

The Bill and Melinda Gates Foundation has spun off a biotech company called The Bill & Melinda Gates Medical Research Institute (MRI) located in Boston. Although it found its temporary space in Cambridge, Massachusetts in January, it “officially” launched Thursday at the BIO International Convention in Boston.

There are generally two types of antidepressants on the market. They are selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). But there are still individuals who do not respond well to these drugs and the industry continues to work on developing better and alternative treatments for depression.

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.